Risk factors
Actinium Pharmaceuticals (ATNM) risk factors
Item 1A of every Actinium Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors64 risks1 dropped11 reworded
The risk profile highlights executive departures, updated tariff regulations following a Supreme Court ruling, and ongoing clinical updates.
Filed Mar 30, 2026 - FY2024 10-K risk factors65 risks
Actinium relies entirely on unapproved radiopharmaceutical candidates with no commercial revenue, facing continuous net losses and capital needs.
Filed Mar 31, 2025